Published on in Vol 5, No 1 (2021): Jan-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28392, first published .
Evaluating the Impact of a Digital Nutrition Platform on Cholesterol Levels in Users With Dyslipidemia: Longitudinal Study

Evaluating the Impact of a Digital Nutrition Platform on Cholesterol Levels in Users With Dyslipidemia: Longitudinal Study

Evaluating the Impact of a Digital Nutrition Platform on Cholesterol Levels in Users With Dyslipidemia: Longitudinal Study

Journals

  1. Bakre S, Shea B, Ortega K, Scharen J, Langheier J, Hu E. Changes in Food Insecurity Among Individuals Using a Telehealth and Nutrition Platform: Longitudinal Study. JMIR Formative Research 2022;6(10):e41418 View
  2. Castela Forte J, Gannamani R, Folkertsma P, Kumaraswamy S, Mount S, van Dam S, Hoogsteen J. Changes in Blood Lipid Levels After a Digitally Enabled Cardiometabolic Preventive Health Program: Pre-Post Study in an Adult Dutch General Population Cohort. JMIR Cardio 2022;6(1):e34946 View
  3. Andargeery S, El-Rafey D. A randomized controlled trial of the effectiveness of the mHealth program in improving the lifestyle of nursing students. Scientific Reports 2025;15(1) View
  4. Jiménez-González C, Alonso-Peña M, Argos Vélez P, Crespo J, Iruzubieta P. Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions. Nutrients 2025;17(9):1580 View
  5. Tang J, Song T, Kuang M, Liu H. Opportunities and challenges of lifestyle intervention-based digital therapeutics in LDL-C management: a scoping review. Therapeutic Advances in Chronic Disease 2025;16 View
  6. Wang H, Shen T, Zhu J, Gao J, Liang S, Yang W, Zhang Z. Effects of Personalized Nutrition Education on Lipid Profiles in Chinese Adults: A Medical Student-Implemented Community Intervention Study. Nutrients 2025;17(13):2161 View
  7. Romeo M, Di Nardo F, Napolitano C, Basile C, Palma C, Vaia P, Dallio M, Federico A. Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review. Diabetology 2025;6(8):79 View
  8. Glenn A, Hu F. Perspective: Food Is Medicine: Hype or Hope?. The Journal of Nutrition 2025;155(11):3654 View